From our Friends at LCGC…Their latest Tweet!
Posted on | August 3, 2010 | Comments Off
A tweet on New Horizons in Reversed-Phase Chromatography http://ow.ly/2iJz3
“In the latest LCGC North America high performance liquid chromatography (HPLC) column survey (1), over 95% of all respondents used reversed-phase chromatography in their daily work. The popularity of this technique is undoubtedly due to its versatility. Reversed-phase chromatography can separate nonpolar, polar, ionizable, and ionic compounds, sometimes at the same time. For mobile phases, reversed-phase chromatography uses water (often buffered) and a water-miscible organic solvent; both are relatively plentiful in most parts of the world in HPLC-grade purity…”
Senior Medical Writer – Medical Communications – London
Posted on | July 30, 2010 | Comments Off
As pharmaceutical scientists in today’s economy, we are often challenged to expand our scope. It the past we pigeonholed ourselves into lab only type carrers. Opportunities that one may have passed up in 2005 are now considered. Scientific writers are a rare breed. One who has a mind for science and a flair for communication. If you are one of those type, then here’s a great opportunity.
A Leading Global Agency based in Central London has the fantastic opportunity for a talented Senior Medical Writer to join their hugely successful team.
As a Senior Writer you will enjoy the responsibility of leading the editorial development and co-ordination of a small and dedicated project team of writers inputting into a range of healthcare materials. This is an excellent opportunity for an already experienced Medical Writer to enjoy more responsibility and strategic input into the development of a team.
Astellas Pharma Closing Two N.Y. Facilities By June 2011
Posted on | July 30, 2010 | Comments Off
“Astellas Pharma Inc. is planning to close two facilities in New York that had been operated by OSI Pharmaceuticals Inc., which the Japanese drug maker bought for $4 billion in June. An Astella spokeswoman said that OSI’s Ardsley and Melville facilities will close by June 2011, affecting about 150 workers at those sites…more“
AstraZeneca Hopeful for Positive FDA Call on Blood-Thinner but Doubts Linger
Posted on | July 29, 2010 | Comments Off
“An FDA advisory committee’s strong vote in favor of AstraZeneca’s (AZN) blood-thinner Brilinta was tempered by long-held concerns over the failure of the drug’s pivotal trial to show a survival benefit in the US population when compared to Plavix (Event – Brilinta has questions to answer, July 21, 2010). With adcom members raising concerns over this unexplained inconsistency in acute coronary syndrome (ACS) patients, there remains the possibility that the FDA will order another trial to sort out the discrepancy…more“
Sanofi fights FDA approval of generic Lovenox
Posted on | June 30, 2010 | Comments Off
“The FDA has approved the first generic version of the blockbuster low molecular weight heparin Lovenox (enoxaparin sodium), much to originator sanofi-aventis’s displeasure. Sanofi has expressed concerns about the generic’s safety and, according to a report from Reuters, has even asked a court to block the approval, claiming that the FDA’s decision was “arbitrary and capricious…more”.
BioSpace Career Fair — Where Life Meets Science
Posted on | May 20, 2010 | Comments Off
Looking for a new job? BioSpace is proud to present the Genetown Career Fair, an opportunity to
meet face-to-face with top companies in the biopharmaceutical market and network with industry
peers.
Genetown Career Fair
Thursday, June 10, 2010
11am to 4pm
Sheraton Boston
Boston, MA
Pre-Register Now: http://news2.biospace.com/ct.html?rtr=on&s=7cmna,dawx,mog,l564,fmqo,i4×5,47tn
Attend the Genetown Career Fair!
Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Northeast region.
